David J Cohen

Summary

Affiliation: Saint Luke's Hospital
Country: USA

Publications

  1. doi request reprint Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention
    Steven P Marso
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, 4401 Wornall Rd, Kansas City, MO 64111, USA
    JAMA 303:2156-64. 2010
  2. doi request reprint Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS a
    David J Cohen
    From Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City D J C, R L O, E A M, K W, H L, K C Erasmus University Medical Center, Rotterdam, The Netherlands R L O, A P K, P W S Harvard School of Public Health, Boston, MA D P Institut Jacques Cartier, Massy, France M C M Boston Scientific, Natick, MA K D D and Herzzentrum Universit├Ąt Leipzig, Leipzig, Germany F W M
    Circulation 130:1146-57. 2014
  3. pmc Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial)
    David J Cohen
    Saint Luke s Mid America Heart and Vascular Institute, 4401 Wornall Road, Kansas City, MO 64111, USA
    J Am Coll Cardiol 58:1557-65. 2011
  4. pmc Interpreting the results of cost-effectiveness studies
    David J Cohen
    Saint Luke s Mid America Heart Institute, Kansas City, Missouri 64111, USA
    J Am Coll Cardiol 52:2119-26. 2008
  5. doi request reprint Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial
    David J Cohen
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City School of Medicine, Kansas City, Missouri 64111, USA
    Catheter Cardiovasc Interv 79:198-209. 2012
  6. doi request reprint Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery
    David J Cohen
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO 64111, USA
    N Engl J Med 364:1016-26. 2011
  7. doi request reprint Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry
    Lakshmi Venkitachalam
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, School of Medicine, 4401 Wornall Rd, Kansas City, MO 64111, USA
    Circulation 124:1028-37. 2011
  8. ncbi request reprint Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PR
    C Michael Gibson
    TIMI Study Group, Cardiovascular Division, Brigham and Women s Hospital, Boston, MA, USA
    Am Heart J 152:756-61. 2006
  9. ncbi request reprint Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial
    David J Cohen
    Harvard Clinical Research Institute, Boston, Mass, USA
    Circulation 110:508-14. 2004
  10. ncbi request reprint Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials
    Donald E Cutlip
    Harvard Clinical Research Institute, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Circulation 110:1226-30. 2004

Collaborators

Detail Information

Publications72

  1. doi request reprint Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention
    Steven P Marso
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, 4401 Wornall Rd, Kansas City, MO 64111, USA
    JAMA 303:2156-64. 2010
    ..The association between the use of bleeding avoidance strategies and post-PCI bleeding as a function of a patient's preprocedural risk of bleeding is unknown...
  2. doi request reprint Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS a
    David J Cohen
    From Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City D J C, R L O, E A M, K W, H L, K C Erasmus University Medical Center, Rotterdam, The Netherlands R L O, A P K, P W S Harvard School of Public Health, Boston, MA D P Institut Jacques Cartier, Massy, France M C M Boston Scientific, Natick, MA K D D and Herzzentrum Universit├Ąt Leipzig, Leipzig, Germany F W M
    Circulation 130:1146-57. 2014
    ..The long-term cost-effectiveness of these strategies is unknown...
  3. pmc Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial)
    David J Cohen
    Saint Luke s Mid America Heart and Vascular Institute, 4401 Wornall Road, Kansas City, MO 64111, USA
    J Am Coll Cardiol 58:1557-65. 2011
    ..The purpose of this study was to compare health-related quality of life (HRQOL) outcomes in patients treated with carotid artery stenting (CAS) versus carotid endarterectomy (CEA)...
  4. pmc Interpreting the results of cost-effectiveness studies
    David J Cohen
    Saint Luke s Mid America Heart Institute, Kansas City, Missouri 64111, USA
    J Am Coll Cardiol 52:2119-26. 2008
    ..Illustrative examples from the cardiology literature are discussed...
  5. doi request reprint Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial
    David J Cohen
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City School of Medicine, Kansas City, Missouri 64111, USA
    Catheter Cardiovasc Interv 79:198-209. 2012
    ..To evaluate the cost-effectiveness of alternative approaches to revascularization for patients with three-vessel or left main coronary artery disease (CAD)...
  6. doi request reprint Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery
    David J Cohen
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO 64111, USA
    N Engl J Med 364:1016-26. 2011
    ..The effect of PCI with the use of drug-eluting stents on these outcomes is unknown...
  7. doi request reprint Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry
    Lakshmi Venkitachalam
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, School of Medicine, 4401 Wornall Rd, Kansas City, MO 64111, USA
    Circulation 124:1028-37. 2011
    ..Although the benefits of drug-eluting stents (DES) for reducing restenosis after percutaneous coronary intervention are well established, the impact of alternative rates of DES use on population-level outcomes is unknown...
  8. ncbi request reprint Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PR
    C Michael Gibson
    TIMI Study Group, Cardiovascular Division, Brigham and Women s Hospital, Boston, MA, USA
    Am Heart J 152:756-61. 2006
    ..A variety of imaging modalities have implicated impaired myocardial perfusion in the pathogenesis of acute coronary syndromes (ACSs)...
  9. ncbi request reprint Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial
    David J Cohen
    Harvard Clinical Research Institute, Boston, Mass, USA
    Circulation 110:508-14. 2004
    ..However, the overall cost-effectiveness of this strategy is unknown...
  10. ncbi request reprint Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials
    Donald E Cutlip
    Harvard Clinical Research Institute, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Circulation 110:1226-30. 2004
    ....
  11. ncbi request reprint Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures
    Allen Jeremias
    Harvard Clinical Research Institute, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    J Am Coll Cardiol 44:1210-4. 2004
    ..This study was designed to evaluate the effect of periprocedural myocardial infarction (MI) on mortality according to success of the stent procedure...
  12. ncbi request reprint A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial
    C Michael Gibson
    TIMI Study Group, Cardiovascular Division, Brigham and Women s Hospital and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
    J Am Coll Cardiol 47:2364-73. 2006
    ....
  13. doi request reprint Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B)
    Matthew R Reynolds
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City School of Medicine, Kansas City, MO 64111, USA
    Circulation 125:1102-9. 2012
    ....
  14. doi request reprint Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at increased surgical risk: results from the SAPPHIRE trial
    Elizabeth M Mahoney
    Cardiovascular Research Center, Saint Luke s Mid America Heart and Vascular Institute, Kansas City, Missouri, USA
    Catheter Cardiovasc Interv 77:463-72. 2011
    ..To evaluate the cost-effectiveness of carotid stenting vs. carotid endarterectomy using data from the SAPPHIRE trial...
  15. doi request reprint Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes
    Duane S Pinto
    Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Am Coll Cardiol 52:1758-68. 2008
    ..The aim of this study was to determine the economic impact of several anticoagulation strategies for moderate- and high-risk non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients managed invasively...
  16. doi request reprint In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry
    Victor Novack
    Harvard Clinical Research Institute, Boston, Massachusetts, USA
    JACC Cardiovasc Interv 2:767-75. 2009
    ..The aim of this study was to compare outcomes among unselected patients undergoing percutaneous coronary intervention (PCI) with either sirolimus-eluting (SES) or paclitaxel-eluting stents (PES)...
  17. doi request reprint Effect of clopidogrel pretreatment on ischemic complications of percutaneous coronary intervention among bivalirudin-treated patients (from the EVENT registry)
    Amit P Amin
    Saint Luke s Mid America Heart and Vascular Institute, Kansas City, Missouri, USA
    Am J Cardiol 107:1751-6. 2011
    ..3%, p = 0.26). In conclusion, among unselected patients undergoing elective PCI with bivalirudin as the planned anticoagulant, clopidogrel pretreatment was common but was not associated with a reduced risk of ischemic complications...
  18. doi request reprint Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons
    Suzanne V Arnold
    St Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 5:267-75. 2012
    ....
  19. doi request reprint Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial
    Suzanne V Arnold
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 2:344-53. 2009
    ..Angina in patients with coronary artery disease is associated with worse quality of life; however, the relationship between angina frequency and resource utilization is unknown...
  20. ncbi request reprint Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial
    Ameet Bakhai
    Harvard Clinical Research Institute, Boston, Massachusetts, USA
    J Am Coll Cardiol 48:253-61. 2006
    ....
  21. pmc Carotid artery stenting of a contralateral occlusion and in-hospital outcomes: results from the CARE (Carotid Artery Revascularization and Endarterectomy) registry
    Nestor Mercado
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, 4401 Wornall Road, Kansas City, MO 64111, USA
    JACC Cardiovasc Interv 6:59-64. 2013
    ..The authors sought to study the characteristics and outcomes of patients with contralateral carotid artery occlusions (CCOs) undergoing elective carotid artery stenting (CAS)...
  22. ncbi request reprint Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial
    David J Cohen
    Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    J Am Coll Cardiol 44:1792-800. 2004
    ..The purpose of this study was to compare the cost of percutaneous coronary intervention (PCI) using bivalirudin with provisional platelet glycoprotein (GP) IIb/IIIa inhibition with that of heparin + routine GP IIb/IIIa inhibition...
  23. ncbi request reprint Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial
    David J Cohen
    Harvard Clinical Research Institute, Boston, Massachusetts, USA
    J Am Coll Cardiol 44:1801-8. 2004
    ..The goal of this research was to determine the incremental cost and cost-effectiveness of embolic protection in patients undergoing percutaneous revascularization (PCI) of diseased saphenous vein bypass grafts (SVGs)...
  24. ncbi request reprint Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial
    Ameet Bakhai
    Harvard Clinical Research Institute, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, Mass 02215, USA
    Circulation 108:2857-63. 2003
    ..Both stenting and the glycoprotein IIb/IIIa inhibitor abciximab improve outcomes for patients undergoing primary angioplasty for acute myocardial infarction (AMI). However, the cost-effectiveness of these strategies is unknown...
  25. ncbi request reprint Effectiveness of rheolytic coronary thrombectomy with the AngioJet catheter
    Stephane Rinfret
    Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Am J Cardiol 90:470-6. 2002
    ..In-hospital and long-term clinical outcomes were favorable. Thus, rheolytic thrombectomy resulted in significant reduction of the thrombus burden in most patients, restored TIMI-3 flow, and led to favorable short- and long-term outcomes...
  26. doi request reprint In-hospital outcomes and cost comparison of femoropopliteal reopening strategies
    David M Safley
    Saint Luke s Mid America Heart Institute, St Luke s Hospital, Kansas City, MO 64111, USA
    Cardiovasc Revasc Med 12:292-8. 2011
    ..Despite increasing use of atherectomy (and higher cost of atherectomy catheters compared with balloon catheters), few studies have compared outcomes and costs with other reopening strategies...
  27. doi request reprint Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry
    Jason B Lindsey
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, Missouri 64111, USA
    JACC Cardiovasc Interv 2:1074-82. 2009
    ..Our aim was to examine the prognostic importance of hemorrhagic and ischemic complications after percutaneous coronary intervention (PCI) in unselected patients...
  28. doi request reprint The impact of bivalirudin on percutaneous coronary intervention-related bleeding
    Jason B Lindsey
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO, USA
    EuroIntervention 6:206-13. 2010
    ..We studied the clinical and economic impact of bivalirudin in clinical practice...
  29. doi request reprint Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleeding
    Amit P Amin
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 3:358-65. 2010
    ....
  30. pmc How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trial
    Suzanne V Arnold
    Saint Luke s Mid America Heart Institute, Kansas City, MO
    Circ Cardiovasc Qual Outcomes 6:591-7. 2013
    ..We sought to evaluate potential definitions of a poor outcome after TAVR that combine both mortality and quality of life components...
  31. ncbi request reprint Effects of stent length and lesion length on coronary restenosis
    Laura Mauri
    Division of Clinical Biometrics, Brigham and Women s Hospital, 1620 Tremont Street, Boston, MA 02120, USA
    Am J Cardiol 93:1340-6, A5. 2004
    ..This analysis supports a conservative approach of matching stent length to lesion length to reduce the risk of restenosis with bare metal stents...
  32. pmc Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at standard surgical risk: results from the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
    Katherine R Vilain
    Saint Luke s Mid America Heart Institute, 4401 Wornall Road, Kansas City, MO 64111, USA
    Stroke 43:2408-16. 2012
    ..Given the large number of patients who are candidates for these procedures, an understanding of their relative cost and cost-effectiveness may have important implications for health care policy and treatment guidelines...
  33. ncbi request reprint Characteristics, management, and outcomes of 5,557 patients age > or =90 years with acute coronary syndromes: results from the CRUSADE Initiative
    Adam H Skolnick
    Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    J Am Coll Cardiol 49:1790-7. 2007
    ..The goal of this work was to explore the treatment and outcomes of patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) age > or =90 years...
  34. doi request reprint Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A)
    Matthew R Reynolds
    Harvard Clinical Research Institute, Boston, Massachusetts, USA
    J Am Coll Cardiol 60:2683-92. 2012
    ..The aim of this study was to evaluate the cost-effectiveness of transcatheter aortic valve replacement (TAVR) compared with surgical aortic valve replacement (AVR) for patients with severe aortic stenosis and high surgical risk...
  35. ncbi request reprint Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry
    John A Spertus
    MPH, Mid America Heart Institute, 4401 Wornall Rd, Kansas City, MO 64111
    Circulation 113:2803-9. 2006
    ..The rate and consequences of prematurely discontinuing thienopyridine therapy after DES placement for acute myocardial infarction (MI) are unknown...
  36. doi request reprint Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry
    Joshua M Stolker
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Interv 3:327-34. 2010
    ..Prediction of restenosis after percutaneous coronary intervention (PCI) remains challenging, and existing risk assessment algorithms were developed before the widespread adoption of drug-eluting stents (DES)...
  37. pmc Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial
    John A Spertus
    Department of Cardiovascular Research, Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO, USA
    Circ Cardiovasc Qual Outcomes 6:409-18. 2013
    ..The predictors and outcomes of patients who crossed over from OMT to revascularization are unknown...
  38. doi request reprint Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial
    Mouin S Abdallah
    Saint Luke s Mid America Heart Institute, Kansas City, Missouri 64111, USA
    JAMA 310:1581-90. 2013
    ..Whether there are treatment differences in health status, as assessed from the patient's perspective, is unknown...
  39. doi request reprint Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry
    Jason B Lindsey
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO 64111, USA
    Circ Cardiovasc Interv 4:474-80. 2011
    ....
  40. doi request reprint Use of the Kansas City Cardiomyopathy Questionnaire for monitoring health status in patients with aortic stenosis
    Suzanne V Arnold
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Heart Fail 6:61-7. 2013
    ..However, its psychometric properties have not yet been evaluated in these patients...
  41. doi request reprint Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events
    Michael J Rinaldi
    Beth Israel Deaconess Medical Center, Boston, MA, USA
    Am Heart J 155:654-60. 2008
    ....
  42. ncbi request reprint Rheolytic thrombectomy and platelet glycoprotein IIb/IIIa blockade for stent thrombosis
    Stephane Rinfret
    Cardiovascular Division, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA
    Catheter Cardiovasc Interv 57:24-30. 2002
    ..A combined approach of rheolytic thrombectomy with adjunctive GP IIb/IIIa blockade was highly effective in resolving stent thrombosis and was associated with favorable acute and long-term outcomes...
  43. ncbi request reprint Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients
    Ramon Kumar
    Department of Medicine, Cardiology Division, Beth Israel Deaconess Medical Center, Boston, MA, USA
    Am J Cardiol 100:1187-91. 2007
    ....
  44. pmc Cost-effectiveness of sirolimus-eluting stents compared with vascular brachytherapy for the treatment of in-stent restenosis
    Matthew R Reynolds
    Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, USA
    Am Heart J 154:1221-7. 2007
    ..Sirolimus-eluting stents (SESs) were recently shown to be superior to vascular brachytherapy for the treatment of restenosis within a bare metal stent. No economic comparison of these alternative strategies has yet been reported...
  45. doi request reprint Survival benefit with drug-eluting stents in observational studies: fact or artifact?
    Lakshmi Venkitachalam
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City School of Medicine, 4401 Wornall Road, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 4:587-94. 2011
    ....
  46. ncbi request reprint Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome
    C Michael Gibson
    TIMI Study Group, Cardiovascular Division, Brigham and Women s Hospital and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 97:1473-7. 2006
    ..In conclusion, patients undergoing DES implantation achieved more reductions in periprocedural markers of inflammation and necrosis than patients receiving bare metal stents among those with non-ST-elevation acute coronary syndrome...
  47. doi request reprint Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasug
    Elizabeth M Mahoney
    Saint Luke s Mid America Heart Institute, 4401 Wornall Rd, Kansas City, MO 64111, USA
    Circulation 121:71-9. 2010
    ..We evaluated the cost-effectiveness of prasugrel versus clopidogrel from the perspective of the US healthcare system by using data from TRITON-TIMI 38...
  48. ncbi request reprint Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials)
    Tobias T Lee
    Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Am J Cardiol 98:718-21. 2006
    ....
  49. doi request reprint Cost-effectiveness of everolimus- versus paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization (from the SPIRIT-IV Trial)
    Amit P Amin
    Saint Luke s Mid America Heart Institute, Kansas City, MO, USA
    Am J Cardiol 110:765-70. 2012
    ..These findings demonstrate that in patients undergoing percutaneous coronary intervention with DESs, use of EESs is economically attractive compared to PESs with improved clinical outcomes and lower overall medical care costs at 2 years...
  50. pmc Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry
    Matthew R Reynolds
    Beth Israel Deaconess Medical Center, Division of Cardiology, Boston, MA 02215, USA
    J Cardiovasc Electrophysiol 18:628-33. 2007
    ..We sought to characterize the resource utilization and costs of treating new-onset AF, with emphasis on the incremental costs associated with recurrent episodes of AF over time...
  51. doi request reprint Association between bleeding events and in-hospital mortality after percutaneous coronary intervention
    Adnan K Chhatriwalla
    Department of Biostatistics, Saint Luke sMid America HeartInstitute, Kansas City, Missouri 64111, USA
    JAMA 309:1022-9. 2013
    ..The incidence of bleeding-related mortality after PCI has not been described in a nationally representative population. Furthermore, the relationships among bleeding risk, bleeding site, and mortality are unclear...
  52. ncbi request reprint Economic implications of bivalirudin in the cardiac catheterization laboratory
    Ameet Bakhai
    Harvard Clinical Research Institute, Boston, Massachusetts, USA
    Rev Cardiovasc Med 7:S35-42. 2006
    ..Whether these benefits can be extended to higher risk patient subsets including patients with non-ST elevation or ST elevation myocardial infarction is currently under investigation...
  53. doi request reprint Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A)
    Matthew R Reynolds
    Harvard Clinical Research Institute, Boston VA Healthcare System, Boston, Massachusetts, USA
    J Am Coll Cardiol 60:548-58. 2012
    ....
  54. ncbi request reprint Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial
    Gregory G Pellizzon
    Mid America Heart Institute, Saint Luke s Hospital, Kansas City, Missouri, USA
    J Am Coll Cardiol 43:1368-74. 2004
    ..We sought to determine the prognostic importance of mitral regurgitation (MR) in patients undergoing percutaneous coronary intervention for acute myocardial infarction (AMI)...
  55. doi request reprint Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial
    Suzanne V Arnold
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 1:107-15. 2008
    ..Ranolazine has been shown to reduce myocardial ischemia and symptom severity among selected patients with chronic angina. However, data regarding the effect of ranolazine on health status/quality of life (QOL) are limited...
  56. ncbi request reprint Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials
    Donald E Cutlip
    Harvard Clinical Research Institute, Boston, Massachusetts 02215, USA
    J Am Coll Cardiol 40:2082-9. 2002
    ..We sought to evaluate clinical restenosis in a large population of patients who had undergone coronary stent placement...
  57. pmc Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study
    Matthew R Reynolds
    Division of Cardiology, Beth Israel Deaconess Medical Center, 185 Pilgrim Road Baker 4, Boston, MA 02215, USA
    Am Heart J 152:1097-103. 2006
    ..We sought to characterize symptoms and QoL in a large inception cohort of unselected patients with AF and explore the impact of age, sex, and AF clinical course on QoL measures over time...
  58. doi request reprint Troponin criteria for myocardial infarction after percutaneous coronary intervention
    Victor Novack
    Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215, USA
    Arch Intern Med 172:502-8. 2012
    ....
  59. ncbi request reprint Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy
    Duane S Pinto
    TIMI Study Group and the Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, 185 Pilgrim Rd, Boston, MA 02115, USA
    Circulation 114:2019-25. 2006
    ..We also hypothesized that in addition to PPCI delays, patient risk factors would significantly modulate the relative survival advantage of PPCI over fibrinolysis...
  60. doi request reprint Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry
    Victor Novack
    Harvard Clinical Research Institute, Boston, Massachusetts, USA
    Catheter Cardiovasc Interv 73:874-80. 2009
    ..To compare clinical outcomes in patients with and without diabetes after multivessel percutaneous coronary intervention (PCI)...
  61. doi request reprint Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performance
    Lakshmi Venkitachalam
    University of Missouri Kansas City School of Medicine, Kansas City, MO, USA
    Circulation 125:1858-69. 2012
    ..An understanding of the relationship between country-level economic and health system factors and elevated cholesterol may provide insight for prioritization of cardiovascular prevention programs...
  62. doi request reprint Selecting antiplatelet therapy at the time of percutaneous intervention for an acute coronary syndrome: weighing the benefits and risks of prasugrel versus clopidogrel
    Adam C Salisbury
    Saint Luke s Mid America Heart and Vascular Institute, and University of Missouri Kansas City, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 6:27-34. 2013
    ..We developed predictive models of the benefits (reduced ischemic events) and risks (increased bleeding) to support targeting prasugrel to those who benefit most from treatment...
  63. pmc Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial
    Suzanne V Arnold
    From Saint Luke s Mid America Heart Institute, Kansas City, MO S V A, Y L, E A M, D J C University of Missouri Kansas City, Kansas City, MO S V A, E A M, D J C Harvard Clinical Research Institute, Boston, MA M R R Columbia Presbyterian Hospital, New York, NY A J K, S K K, P G, M B L Washington University, St Louis, MO A Z Emory University School of Medicine, Atlanta, GA V H T Laval University, Quebec, Canada J R C Columbia University Division of Cardiology at Mount Sinai Medical Center, Miami Beach, FL N B and Baylor Healthcare System, Plano, TX M J M
    Circulation 129:2682-90. 2014
    ..We sought to identify patients at high risk for poor outcome after TAVR using a novel definition of outcome that integrates quality of life with mortality...
  64. pmc Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial
    Elizabeth A Magnuson
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circulation 127:820-31. 2013
    ..Whether these results apply in the drug-eluting stent (DES) era is unknown...
  65. doi request reprint Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States
    Elizabeth M Mahoney
    Saint Luke s Mid America Heart and Vascular Institute, Kansas City, MO, USA
    Circ Cardiovasc Qual Outcomes 3:642-51. 2010
    ....
  66. ncbi request reprint Cost-effectiveness of alternative approaches to the management of chronic obstructive coronary artery disease
    Amit P Amin
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO, USA
    Rev Cardiovasc Med 10:S3-13. 2009
    ....
  67. doi request reprint Health-related quality of life following carotid stenting versus endarterectomy: results from the SAPPHIRE (Stenting and Angioplasty with Protection in Patients at HIgh Risk for Endarterectomy) trial
    Joshua M Stolker
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, Missouri, USA
    JACC Cardiovasc Interv 3:515-23. 2010
    ..This study compared health-related quality of life in patients undergoing carotid artery stenting (CAS) versus surgical endarterectomy (CEA)...
  68. doi request reprint The impact of dyspnea on health-related quality of life in patients with coronary artery disease: results from the PREMIER registry
    Suzanne V Arnold
    Saint Luke s Mid America Heart Institute, Kansas City, MO, USA
    Am Heart J 157:1042-9.e1. 2009
    ..Both angina and dyspnea are prevalent symptoms among post-myocardial infarction (MI) patients. Given their frequent overlap, little is known about the degree to which these symptoms provide independent information in this population...
  69. doi request reprint Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry)
    Andrew D Frutkin
    Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO 64111, USA
    JACC Cardiovasc Interv 2:614-21. 2009
    ..Our purpose was to evaluate percutaneous coronary intervention (PCI) attempt rates in patients with class I indications for coronary artery bypass graft (CABG) surgery after the introduction of drug-eluting stents (DES)...
  70. doi request reprint Cost-effectiveness of oral antiplatelet agents--current and future perspectives
    Suzanne V Arnold
    Saint Luke s Mid America Heart Institute, 4401 Wornall Road, Kansas City, MO 64111, USA
    Nat Rev Cardiol 8:580-91. 2011
    ....
  71. pmc Concordance of physician ratings with the appropriate use criteria for coronary revascularization
    Paul S Chan
    Saint Luke s Mid America Heart Institute, Kansas City, Missouri 64111, USA
    J Am Coll Cardiol 57:1546-53. 2011
    ..The objective of this study was to compare the consistency in appropriate use criteria (AUC) ratings among a broad range of practicing cardiologists and the AUC Technical Panel...
  72. doi request reprint One-year costs in patients with a history of or at risk for atherothrombosis in the United States
    Elizabeth M Mahoney
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 1:38-45. 2008
    ....